Genetic testing for hereditary mutation of the von Hippel-Lindau (VHL) gene
Medical Services Advisory Committee
Record ID 32011000604
English
Authors' recommendations:
After considering the strength of the available evidence in relation to the safety, effectiveness and cost-effectiveness of genetic testing to evaluate von Hippel-Lindau disease, MSAC supported public funding for listing three tests on the MBS, as follows:
- Diagnostic test for heritable mutation in affected patient
- Predictive test for heritable mutation in relative of person with a heritable mutation
- Diagnostic test for somatic mutations in patient with VHL syndrome and normal germline study.
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.msac.gov.au/internet/msac/publishing.nsf/Content/1153-public
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Genetic Predisposition to Disease
- Mutation
- von Hippel-Lindau Disease
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
<p>Medical Services Advisory Committee (MSAC)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.